US6423546B1ExpiredUtility

Monoclonal antibodies for assaying lipid transfer proteins

Assignee: MILLER BREWINGPriority: Nov 2, 2000Filed: Nov 2, 2000Granted: Jul 23, 2002
Est. expiryNov 2, 2020(expired)· nominal 20-yr term from priority
C07K 2317/34A61K 38/00Y10S530/864C07K 16/16Y10S530/866Y10S435/975Y10S436/808
81
PatentIndex Score
8
Cited by
43
References
7
Claims

Abstract

The present invention relates to novel monoclonal antibodies reactive with lipid transfer proteins typically found in foaming beverages. More specifically, the present invention relates to novel monoclonal antibodies raised against the native and denatured forms of barley lipid transfer protein 1, and an assay for determining the content of said proteins in foaming beverages at various stages of their production.

Claims

exact text as granted — not AI-modified
We claim:  
     
       1. A monoclonal antibody produced by a hybridoma selected from the group consisting of hybridoma 3F7.1 having ATCC accession number PTA-2475, hybridoma 2C12.1 having ATCC accession number PTA-2472, hybridoma 3G1.1 having ATCC accession number PTA-2476, hybridoma 3D1.1 having ATCC accession number PTA-2473, hybridoma 3D11.1 having ATCC accession number PTA-2477, and hybridoma 2E3.1 having ATCC accession number PTA-2474. 
     
     
       2. A fragment of the monoclonal antibody of  claim 1 , the fragment comprising at least a portion of the antigen-binding region of the monoclonal antibody, wherein said portion is able to bind to the same antigenic determinant as does the monoclonal antibody. 
     
     
       3. An assay kit comprising a first antibody produced by a hybridoma selected from the group consisting of hybridoma 3F7.1 having ATCC accession number PTA-2475, hybridoma 2C12.1 having ATCC accession number PTA-2472, hybridoma 3G1.1 having ATCC accession number PTA-2476, hybridoma 3D1.1 having ATCC accession number PTA-2473, hybridoma 3D11.1 having ATCC accession number PTA-2477, and hybridoma 2E3.1 having ATCC accession number PTA-2474, a first conjugate comprising a specific binding partner for the first antibody, and a label capable of producing a signal that identifies the presence of the first antibody. 
     
     
       4. The assay kit of  claim 3  further comprising a second antibody produced by a hybridoma selected from the group consisting of hybridoma 3F7.1 having ATCC accession number PTA-2475, hybridoma 2C12.1 having ATCC accession number PTA-2472, hybridoma 3G1.1 having ATCC accession number PTA-2476, hybridoma 3D1.1 having ATCC accession number PTA-2473, hybridoma 3D11.1 having ATCC accession number PTA-2477, and hybridoma 2E3.1 having ATCC accession number PTA-2474, wherein the second antibody is different than the first antibody, a second conjugate comprising a specific binding partner for the second antibody. 
     
     
       5. An antigen-binding fragment that specifically binds to plant lipid transfer proteins, said antigen-binding fragment capable of binding to the same antigenic determinant as does a monoclonal antibody produced by a hybridoma selected from the group consisting of hybridoma 3F7.1 having ATCC accession number PTA-2475, hybridoma 2C12.1 having ATCC accession number PTA-2472, hybridoma 3G1.1 having ATCC accession number PTA-2476, hybridoma 3D1.1 having ATCC accession number PTA-2473, hybridoma 3D11.1 having ATCC accession number PTA-2477, and hybridoma 2E3.1 having ATCC accession number PTA-2474. 
     
     
       6. The antigen-binding fragment of  claim 5  wherein the fragment is either a monoclonal antibody or a polyclonal antibody. 
     
     
       7. A hybridoma selected from the group consisting of hybridoma 3F7.1 having ATCC accession number PTA-2475, hybridoma 2C12.1 having ATCC accession number PTA-2472, hybridoma 3G1.1 having ATCC accession number PTA-2476, hybridoma 3D1.1 having ATCC accession number PTA-2473, hybridoma 3D11.1 having ATCC accession number PTA-2477, and hybridoma 2E3.1 having ATCC accession number PTA-2474.

Join the waitlist — get patent alerts

Track US6423546B1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.